microRNA‑155 promotes the proliferation of prostate cancer cells by targeting annexin 7

Cai,Zhi‑Kang; Chen,Qi; Chen,Yan‑Bo; Gu,Meng; Zheng,Da‑Chao; Zhou,Juan; Wang,Zhong

doi:10.3892/mmr.2014.2744

microRNA‑155 promotes the proliferation of prostate cancer cells by targeting annexin 7

Authors:
- Zhi‑Kang Cai
- Qi Chen
- Yan‑Bo Chen
- Meng Gu
- Da‑Chao Zheng
- Juan Zhou
- Zhong Wang
View Affiliations

Affiliations: Department of Urology and Andrology, Ninth People's Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai 200011, P.R. China
Published online on: October 22, 2014 https://doi.org/10.3892/mmr.2014.2744
Pages: 533-538

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Micro (mi)RNAs are a group of small non‑coding RNA molecules that have been demonstrated to regulate the expression of genes involved in tumorigenesis. The relevance of microRNAs in the development, progression and prognosis of prostate cancer is not fully understood. miR‑155 has been implicated in the induction of breast, lung and liver cancer, but its role in prostate cancer has not been investigated. In the present study, the biological function of miR‑155 was investigated in prostate cancer for the first time, to the best of our knowledge. It was demonstrated that the expression of miR‑155 was upregulated in prostate cancer tissues and cell lines as determined by quantitative reverse transcription‑polymerase chain reaction. Furthermore, overexpression of miR‑155 promoted cell proliferation, as indicated by MTT assay. Flow cytometric analysis demonstrated that inhibition of miR‑155 induced cell cycle arrest and promoted apoptosis in prostate cancer cells. In addition, western blot analysis indicated that annexin (ANX)7 was significantly downregulated in prostate cancer tissues and cells. A luciferase reporter assay indicated that ANX7 was a target of miR‑155, which suggested that miRNA‑155 promoted the proliferation of prostate cancer cells by regulating ANX7 expression levels.

View Figures

View References

1	Dunn MW and Kazer MW: Prostate cancer overview. Semin Oncol Nurs. 27:241–250. 2011. View Article : Google Scholar
2	Ha HK, Lee W, Park HJ, et al: Clinical significance of CXCL16/CXCR6 expression in patients with prostate cancer. Mol Med Rep. 4:419–424. 2011.PubMed/NCBI
3	Gosselaar C, Roobol MJ, Roemeling S, van der Kwast TH and Schröder FH: Screening for prostate cancer at low PSA range: the impact of digital rectal examination on tumor incidence and tumor characteristics. Prostate. 67:154–161. 2007. View Article : Google Scholar : PubMed/NCBI
4	Katahira K, Takahara T, Kwee TC, et al: Ultra-high-b-value diffusion-weighted MR imaging for the detection of prostate cancer: evaluation in 201 cases with histopathological correlation. Eur Radiol. 21:188–196. 2011. View Article : Google Scholar
5	Stewart GD, Gray K, Pennington CJ, et al: Analysis of hypoxia-associated gene expression in prostate cancer: lysyl oxidase and glucose transporter-1 expression correlate with Gleason score. Oncol Rep. 20:1561–1567. 2008.PubMed/NCBI
6	Arora R, Koch MO, Eble JN, et al: Heterogeneity of Gleason grade in multifocal adenocarcinoma of the prostate. Cancer. 100:2362–2366. 2004. View Article : Google Scholar : PubMed/NCBI
7	Jiang YW and Chen LA: microRNAs as tumor inhibitors, oncogenes, biomarkers for drug efficacy and outcome predictors in lung cancer (review). Mol Med Rep. 5:890–894. 2012.PubMed/NCBI
8	Fang YX and Gao WQ: Roles of microRNAs during prostatic tumorigenesis and tumor progression. Oncogene. 2013.PubMed/NCBI
9	Hamamoto J, Soejima K, Yoda S, et al: Identification of microRNAs differentially expressed between lung squamous cell carcinoma and lung adenocarcinoma. Mol Med Rep. 8:456–462. 2013.PubMed/NCBI
10	Nazarov PV, Reinsbach SE, Muller A, et al: Interplay of microRNAs, transcription factors and target genes: linking dynamic expression changes to function. Nucleic Acids Res. 41:2817–2831. 2013. View Article : Google Scholar : PubMed/NCBI
11	Marcucci G, Maharry KS, Metzeler KH, et al: Clinical role of microRNAs in cytogenetically normal acute myeloid leukemia: miR-155 upregulation independently identifies high-risk patients. J Clin Oncol. 31:2086–2093. 2013. View Article : Google Scholar : PubMed/NCBI
12	Yang M, Shen H, Qiu C, et al: High expression of miR-21 and miR-155 predicts recurrence and unfavourable survival in non-small cell lung cancer. Eur J Cancer. 49:604–615. 2013. View Article : Google Scholar : PubMed/NCBI
13	Huang X, Taeb S, Jahangiri S, et al: MiRNA-95 mediates radioresistance in tumors by targeting the sphingolipid phosphatase SGPP1. Cancer Res. 2013.PubMed/NCBI
14	Huang X and Jia Z: Construction of HCC-targeting artificial miRNAs using natural miRNA precursors. Exp Ther Med. 6:209–215. 2013.PubMed/NCBI
15	Shi XB, Xue L, Ma AH, et al: MiR-125b promotes growth of prostate cancer xenograft tumor through targeting pro-apoptotic genes. Prostate. 71:538–549. 2011. View Article : Google Scholar : PubMed/NCBI
16	Zhang CM, Zhao J and Deng HY: MiR-155 promotes proliferation of human breast cancer MCF-7 cells through targeting tumor protein 53-induced nuclear protein 1. J Biomed Sci. 20:792013. View Article : Google Scholar : PubMed/NCBI
17	Powell-Coffman JA and Coffman CR: Apoptosis: Lack of oxygen aids cell survival. Nature. 465:554–555. 2010. View Article : Google Scholar : PubMed/NCBI
18	Li T, Kon N, Jiang L, et al: Tumor suppression in the absence of p53-mediated cell-cycle arrest, apoptosis, and senescence. Cell. 149:1269–1283. 2012. View Article : Google Scholar : PubMed/NCBI
19	Petrocca F, Visone R, Onelli MR, et al: E2F1-regulated microRNAs impair TGFbeta-dependent cell-cycle arrest and apoptosis in gastric cancer. Cancer Cell. 13:272–286. 2008. View Article : Google Scholar : PubMed/NCBI
20	Higgs G and Slack F: The multiple roles of microRNA-155 in Oncogenesis. J Clin Bioinforma. 3:172013. View Article : Google Scholar : PubMed/NCBI
21	Streicher WW, Lopez MM and Makhatadze GI: Annexin I and annexin II N-terminal peptides binding to S100 protein family members: specificity and thermodynamic characterization. Biochemistry. 48:2788–2798. 2009. View Article : Google Scholar : PubMed/NCBI
22	Lokman NA, Ween MP, Oehler MK and Ricciardelli C: The role of annexin A2 in tumorigenesis and cancer progression. Cancer Microenviron. 4:199–208. 2011. View Article : Google Scholar : PubMed/NCBI
23	Paweletz CP, Ornstein DK, Roth MJ, et al: Loss of annexin 1 correlates with early onset of tumorigenesis in esophageal and prostate carcinoma. Cancer Res. 60:6293–6297. 2000.PubMed/NCBI
24	Jin Y, Wang S, Chen W, et al: Annexin A7 suppresses lymph node metastasis of hepatocarcinoma cells in a mouse model. BMC Cancer. 13:5222013. View Article : Google Scholar : PubMed/NCBI
25	Srivastava M, Bubendorf L, Srikantan V, et al: ANX7, a candidate tumor suppressor gene for prostate cancer. Proc Natl Acad Sci USA. 98:4575–4580. 2001. View Article : Google Scholar : PubMed/NCBI